Compare LGVN & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | ANGH |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United Arab Emirates |
| Employees | N/A | 186 |
| Industry | Medicinal Chemicals and Botanical Products | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 36.3M |
| IPO Year | 2021 | N/A |
| Metric | LGVN | ANGH |
|---|---|---|
| Price | $1.04 | $3.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 889.7K | 2.5K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $709,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $0.25 |
| 52 Week High | $1.83 | $7.05 |
| Indicator | LGVN | ANGH |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 55.98 |
| Support Level | $0.69 | $2.83 |
| Resistance Level | $1.23 | $4.06 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 33.87 | 62.21 |
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.